A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a “modest” effect on immune systems in a small, early trial, according to a new study. The trial marks the first time a vaccine whose active ingredient was entirely designed by AI has been tested in humans, researchers at the University of Cambridge in the U.K. said…
